Theravance Biopharma First Quarter 2024 Earnings: Beats Expectations

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates

Q1 2024 Theravance Biopharma Inc Earnings Call Transcript

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates

Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates

Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma to Participate in an Upcoming Investor Conference

Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

BTIG Research Predicts Over 118% Rally for These 3 Stocks

BTIG Research Predicts Over 118% Rally for These 3 Stocks

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?